Knott David M Jr Leap Therapeutics, Inc. Transaction History

Knott David M Jr

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.29 - $0.72 $81,797 - $203,083	-282,061 Reduced 33.58%	557,939 $190,000
Q4 2022 Feb 13, 2023	SELL	$0.42 - $0.78 $25,200 - $46,800	-60,000 Reduced 6.67%	840,000 $378,000
Q3 2022 Nov 10, 2022	BUY	$0.92 - $1.75 $451,763 - $859,332	491,047 Added 120.07%	900,000 $792,000
Q2 2022 Aug 11, 2022	BUY	$0.96 - $1.91 $368,498 - $733,159	383,853 Added 1529.29%	408,953 $470,000
Q1 2022 May 16, 2022	BUY	$1.6 - $3.35 $40,160 - $84,085	25,100 New	25,100 $44,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $198M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.